These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


334 related items for PubMed ID: 34518478

  • 1. Activation of SIRT1 by Resveratrol Alleviates Pressure Overload-Induced Cardiac Hypertrophy via Suppression of TGF-β1 Signaling.
    Chen Y, He T, Zhang Z, Zhang J.
    Pharmacology; 2021; 106(11-12):667-681. PubMed ID: 34518478
    [Abstract] [Full Text] [Related]

  • 2. SIRT1 activation ameliorates rhesus monkey liver fibrosis by inhibiting the TGF-β/smad signaling pathway.
    Xia Y, Luo Q, Gao Q, Huang C, Chen P, Zou Y, Chen X, Liu W, Chen Z.
    Chem Biol Interact; 2024 May 01; 394():110979. PubMed ID: 38555046
    [Abstract] [Full Text] [Related]

  • 3. Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
    Huang XZ, Wen D, Zhang M, Xie Q, Ma L, Guan Y, Ren Y, Chen J, Hao CM.
    J Cell Biochem; 2014 May 01; 115(5):996-1005. PubMed ID: 24356887
    [Abstract] [Full Text] [Related]

  • 4. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.
    Fang WJ, Wang CJ, He Y, Zhou YL, Peng XD, Liu SK.
    Acta Pharmacol Sin; 2018 Jan 01; 39(1):59-73. PubMed ID: 28770830
    [Abstract] [Full Text] [Related]

  • 5. Resveratrol ameliorates myocardial fibrosis by regulating Sirt1/Smad3 deacetylation pathway in rat model with dilated cardiomyopathy.
    Chen Q, Zeng Y, Yang X, Wu Y, Zhang S, Huang S, Zhong Y, Chen M.
    BMC Cardiovasc Disord; 2022 Jan 26; 22(1):17. PubMed ID: 35081907
    [Abstract] [Full Text] [Related]

  • 6. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
    Yan L, Wei X, Tang QZ, Feng J, Zhang Y, Liu C, Bian ZY, Zhang LF, Chen M, Bai X, Wang AB, Fassett J, Chen Y, He YW, Yang Q, Liu PP, Li H.
    Cardiovasc Res; 2011 Oct 01; 92(1):85-94. PubMed ID: 21632881
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of transforming growth factor-beta1 on rat cardiocyte hypertrophy].
    Huang J, Wei CY, Zheng ZQ, Wu YP, Deng YX.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Aug 01; 22(3):283-7. PubMed ID: 21158069
    [Abstract] [Full Text] [Related]

  • 9. Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation.
    Bugyei-Twum A, Ford C, Civitarese R, Seegobin J, Advani SL, Desjardins JF, Kabir G, Zhang Y, Mitchell M, Switzer J, Thai K, Shen V, Abadeh A, Singh KK, Billia F, Advani A, Gilbert RE, Connelly KA.
    Cardiovasc Res; 2018 Oct 01; 114(12):1629-1641. PubMed ID: 29800064
    [Abstract] [Full Text] [Related]

  • 10. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
    Huang K, Huang J, Xie X, Wang S, Chen C, Shen X, Liu P, Huang H.
    Free Radic Biol Med; 2013 Dec 01; 65():528-540. PubMed ID: 23891678
    [Abstract] [Full Text] [Related]

  • 11. Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway.
    Zhang Y, Shao L, Ma A, Guan G, Wang J, Wang Y, Tian G.
    Hypertens Res; 2014 Jan 01; 37(1):43-9. PubMed ID: 24089264
    [Abstract] [Full Text] [Related]

  • 12. FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway.
    Jin D, Han F.
    J Recept Signal Transduct Res; 2020 Dec 01; 40(6):493-500. PubMed ID: 32496870
    [Abstract] [Full Text] [Related]

  • 13. Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression.
    Ma Y, Chen Y, Yang Y, Chen B, Liu D, Xiong Z, Zhang C, Dong Y.
    Biochem Pharmacol; 2013 Jan 15; 85(2):223-33. PubMed ID: 23142711
    [Abstract] [Full Text] [Related]

  • 14. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    Ding J, Tang Q, Luo B, Zhang L, Lin L, Han L, Hao M, Li M, Yu L, Li M.
    Eur J Pharmacol; 2019 Sep 15; 859():172549. PubMed ID: 31325434
    [Abstract] [Full Text] [Related]

  • 15. Resveratrol improves left ventricular remodeling in chronic kidney disease via Sirt1-mediated regulation of FoxO1 activity and MnSOD expression.
    Li P, Song X, Zhang D, Guo N, Wu C, Chen K, Liu Y, Yuan L, Chen X, Huang X.
    Biofactors; 2020 Jan 15; 46(1):168-179. PubMed ID: 31688999
    [Abstract] [Full Text] [Related]

  • 16. Effects of transforming growth factor-beta1 and signal protein Smad3 on rat cardiomyocyte hypertrophy.
    Huang J, Qin GH, Hu CX, Gong LY, Cheng FZ, Ma YX, Lu ZY.
    Chin Med J (Engl); 2004 Oct 15; 117(10):1471-5. PubMed ID: 15498367
    [Abstract] [Full Text] [Related]

  • 17. Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway.
    Ren B, Feng J, Yang N, Guo Y, Chen C, Qin Q.
    Int Immunopharmacol; 2021 Sep 15; 98():107841. PubMed ID: 34153662
    [Abstract] [Full Text] [Related]

  • 18. Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction.
    Zhang L, Chen J, Yan L, He Q, Xie H, Chen M.
    Front Pharmacol; 2021 Sep 15; 12():646240. PubMed ID: 34177571
    [Abstract] [Full Text] [Related]

  • 19. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition.
    Zhao L, Mi Y, Guan H, Xu Y, Mei Y.
    Eur J Pharmacol; 2016 Jul 15; 783():33-46. PubMed ID: 27108788
    [Abstract] [Full Text] [Related]

  • 20. Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice.
    Goh KY, He L, Song J, Jinno M, Rogers AJ, Sethu P, Halade GV, Rajasekaran NS, Liu X, Prabhu SD, Darley-Usmar V, Wende AR, Zhou L.
    Redox Biol; 2019 Feb 15; 21():101100. PubMed ID: 30641298
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.